The Children’s Cancer Therapy Development Institute is a unique 501c3 non-profit organization focused on the ‘preclinical gap’ in childhood cancer research. cc-TDI was built to complement the Children’s Oncology Group & related clinical trial networks while synergizing with both academic laboratories and pharma R&D laboratories.

Our mission is to bridge scientific discovery and the initiation of clinical trials. We provide evidence-based testing for a selection of new drugs to be used in childhood cancer clinical trials, thus seeding pediatric Phase I and II trials. This concept was emphasized in the Institute of Medicine Report, Making Better Drugs for Children with Cancer in 2005